Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
Authors
Keywords
Acne vulgaris, Ciglitazone, Cutaneous malignancy, Dioic acid, PPARs, PPAR agonists, Peroxisome proliferator-activated receptors, Pioglitazone, Psoriasis, Rosiglitazone, Scleroderma, Thiazolidinediones, Troglitazone, Zileuton
Journal
ARCHIVES OF DERMATOLOGICAL RESEARCH
Volume 307, Issue 9, Pages 767-780
Publisher
Springer Nature
Online
2015-05-18
DOI
10.1007/s00403-015-1571-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Pro12Ala polymorphism of the gene for peroxisome proliferator activated receptor-gamma is associated with a lower Global Acne Grading System score in patients with acne vulgaris
- (2014) K. Amr et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- The efficacy of methotrexate plus pioglitazone vs. methotrexate alone in the management of patients with plaque-type psoriasis: a single-blinded randomized controlled trial
- (2014) Vahide Lajevardi et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Role of PPAR, LXR, and PXR in epidermal homeostasis and inflammation
- (2013) Matthias Schmuth et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Topical application of PPARα (but not β/δ or γ) suppresses atopic dermatitis in NC/Nga mice
- (2012) T. Chiba et al. ALLERGY
- Skin-Targeted Inhibition of PPAR β/δ by Selective Antagonists to Treat PPAR β/δ – Mediated Psoriasis-Like Skin Disease In Vivo
- (2012) Katrin Hack et al. PLoS One
- Peroxisome proliferator-activated receptor activators protect sebocytes from apoptosis: a new treatment modality for acne?
- (2010) M. Schuster et al. BRITISH JOURNAL OF DERMATOLOGY
- A Meta-Analysis of Six Placebo-Controlled Trials of Thiazolidinedione Therapy for HIV Lipoatrophy
- (2010) Janet M. Raboud et al. HIV CLINICAL TRIALS
- Peroxisome proliferator-activated receptor δ agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis
- (2010) Saravanan Kanakasabai et al. IMMUNOLOGY
- PPARβ activation inhibits melanoma cell proliferation involving repression of the Wilms’ tumour suppressor WT1
- (2010) Jean-François Michiels et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Activation of PPARβ/δ Causes a Psoriasis-Like Skin Disease In Vivo
- (2010) Malgorzata Romanowska et al. PLoS One
- Peroxisome Proliferator-Activated Receptors (PPARs) and the Human Skin
- (2009) Pit Sertznig et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Rosiglitazone Abrogates Bleomycin-Induced Scleroderma and Blocks Profibrotic Responses Through Peroxisome Proliferator-Activated Receptor-γ
- (2009) Minghua Wu et al. AMERICAN JOURNAL OF PATHOLOGY
- Lichen Planopilaris Treated With a Peroxisome Proliferator–Activated Receptor γ Agonist
- (2009) Paradi Mirmirani ARCHIVES OF DERMATOLOGY
- Loss of peroxisome proliferator-activated receptor γ in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis
- (2009) Mohit Kapoor et al. ARTHRITIS AND RHEUMATISM
- Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis
- (2009) Marianne Demerjian et al. EXPERIMENTAL DERMATOLOGY
- Efficacy of dioic acid compared with hydroquinone in the treatment of melasma
- (2009) Andrés Tirado-Sánchez et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Murine atopic dermatitis responds to peroxisome proliferator-activated receptors α and β/δ (but not γ) and liver X receptor activators
- (2009) Yutaka Hatano et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The nuclear receptor PPARγ selectively inhibits Th17 differentiation in a T cell–intrinsic fashion and suppresses CNS autoimmunity
- (2009) Luisa Klotz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In Vitro and In Vivo Anti-Melanoma Effects of Ciglitazone
- (2009) Thomas Botton et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Benefits of Sunflower Oleodistillate (SOD) in Pediatric Dermatology
- (2009) Lawrence F. Eichenfield et al. PEDIATRIC DERMATOLOGY
- Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblasts
- (2009) X. Shi-wen et al. RHEUMATOLOGY
- A Retrospective Case Series Review of the Peroxisome Proliferator-Activated Receptor Ligand Rosiglitazone in the Treatment of Atopic Dermatitis
- (2008) Ramona Behshad et al. ARCHIVES OF DERMATOLOGY
- Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials
- (2008) J. Schmitt et al. BRITISH JOURNAL OF DERMATOLOGY
- Peroxisome proliferator-activated receptor α regulates skin inflammation and humoral response in atopic dermatitis
- (2008) Delphine Staumont-Sallé et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Hair Follicle Stem Cell-Specific PPARγ Deletion Causes Scarring Alopecia
- (2008) Pratima Karnik et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Effects of Thiazolidinediones on Metabolic Complications and Lipodystrophy in HIV-Infected Patients
- (2008) Jussi Sutinen PPAR Research
- Antiretroviral-Related Adipocyte Dysfunction and Lipodystrophy in HIV-Infected Patients: Alteration of the PPARγ-Dependent Pathways
- (2008) Martine Caron et al. PPAR Research
- Deficiency of PPARβ/δ in the Epidermis Results in Defective Cutaneous Permeability Barrier Homeostasis and Increased Inflammation
- (2007) Mao-Qiang Man et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation